Clinical Trial Update: Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL). [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on conventional versus accelerated corneal collagen cross-linking for keratoconus and corneal ectasia, covering Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Snippet

Sponsor: Oslo University Hospital | Conditions: Keratoconus, Corneal Ectasia | Phase 1, Phase 2 | Status: UNKNOWN